Clinical trial
Effects of Antiviral Therapies on Epstein-Barr Virus Replication
NCT05957913 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Antiviral Therapies on Epstein-Barr Virus Replication
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 2
- Overall status
- Enrolling by invitation
- Start date
- June 5, 2023
- Completion date
- December 31, 2027
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.